Sartorius Stedim Biotech Statistics

Total Valuation

LON:0RG8 has a market cap or net worth of GBP 16.76 billion. The enterprise value is 18.70 billion.

Market Cap	16.76B
Enterprise Value	18.70B

Important Dates

The last earnings date was Wednesday, April 16, 2025.

Earnings Date	Apr 16, 2025
Ex-Dividend Date	Apr 2, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+3.64%
Shares Change (QoQ)	+0.09%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	27.74M

Valuation Ratios

The trailing PE ratio is 98.08.

PE Ratio	98.08
Forward PE	n/a
PS Ratio	7.01
PB Ratio	5.00
P/TBV Ratio	n/a
P/FCF Ratio	34.33
P/OCF Ratio	22.78
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 31.89, with an EV/FCF ratio of 38.30.

EV / Earnings	109.40
EV / Sales	7.65
EV / EBITDA	31.89
EV / EBIT	52.24
EV / FCF	38.30

Financial Position

The company has a current ratio of 1.85, with a Debt / Equity ratio of 0.73.

Current Ratio	1.85
Quick Ratio	1.04
Debt / Equity	0.73
Debt / EBITDA	4.23
Debt / FCF	5.03
Interest Coverage	2.62

Financial Efficiency

Return on equity (ROE) is 5.25% and return on invested capital (ROIC) is 3.81%.

Return on Equity (ROE)	5.25%
Return on Assets (ROA)	3.19%
Return on Invested Capital (ROIC)	3.81%
Return on Capital Employed (ROCE)	5.82%
Revenue Per Employee	240,001
Profits Per Employee	17,158
Employee Count	9,901
Asset Turnover	0.34
Inventory Turnover	2.06

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -17.32% in the last 52 weeks. The beta is 0.98, so LON:0RG8's price volatility has been similar to the market average.

Beta (5Y)	0.98
52-Week Price Change	-17.32%
50-Day Moving Average	191.36
200-Day Moving Average	186.59
Relative Strength Index (RSI)	61.09
Average Volume (20 Days)	67,836

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, LON:0RG8 had revenue of GBP 2.39 billion and earned 170.91 million in profits. Earnings per share was 1.77.

Revenue	2.39B
Gross Profit	1.05B
Operating Income	357.05M
Pretax Income	215.16M
Net Income	170.91M
EBITDA	558.41M
EBIT	357.05M
Earnings Per Share (EPS)	1.77

Full Income Statement

Balance Sheet

The company has 591.95 million in cash and 2.45 billion in debt, giving a net cash position of -1.86 billion.

Cash & Cash Equivalents	591.95M
Total Debt	2.45B
Net Cash	-1.86B
Net Cash Per Share	n/a
Equity (Book Value)	3.35B
Book Value Per Share	34.16
Working Capital	682.05M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 735.76 million and capital expenditures -247.54 million, giving a free cash flow of 488.22 million.

Operating Cash Flow	735.76M
Capital Expenditures	-247.54M
Free Cash Flow	488.22M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 43.89%, with operating and profit margins of 14.94% and 7.15%.

Gross Margin	43.89%
Operating Margin	14.94%
Pretax Margin	9.00%
Profit Margin	7.15%
EBITDA Margin	23.36%
EBIT Margin	14.94%
FCF Margin	20.42%

Dividends & Yields

This stock pays an annual dividend of 0.58, which amounts to a dividend yield of 0.36%.

Dividend Per Share	0.58
Dividend Yield	0.36%
Dividend Growth (YoY)	-2.25%
Years of Dividend Growth	n/a
Payout Ratio	32.84%
Buyback Yield	-3.64%
Shareholder Yield	-3.28%
Earnings Yield	1.02%
FCF Yield	2.91%

Dividend Details

Stock Splits

The last stock split was on May 6, 2016. It was a forward split with a ratio of 6.

Last Split Date	May 6, 2016
Split Type	Forward
Split Ratio	6

Scores

LON:0RG8 has an Altman Z-Score of 3.64.

Altman Z-Score	3.64
Piotroski F-Score	n/a